Filing Flows › Comparisons › SIBN vs TMCI
Si-Bone vs Treace Medical Concepts: SIBN and TMCI compared
Si-Bone is the larger company: $55.7M of revenue in its latest quarter (Q3 2026) against $48.3M for Treace Medical Concepts (Q3 2026). Si-Bone is growing faster (+14% against -4% a year earlier). Si-Bone is more profitable, with an operating margin of -7.8% against -23.9%.
Where the money goes: SIBN and TMCI
Si-Bone (SIBN) · Q3 2026
Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%, net loss $3.6M, operating cash flow $5.9M. The chart follows the revenue to costs, profit and cash.
Treace Medical Concepts (TMCI) · Q3 2026
Treace Medical Concepts, Q3 2026: revenue $48.3M (-4% year over year), operating margin -23.9%, net loss $12.6M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
| Si-Bone (SIBN) | Treace Medical Concepts (TMCI) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $55.7M | $48.3M |
| Revenue growth, Y/Y | +14% | -4% |
| Operating margin | -7.8% | -23.9% |
| Net earnings | −$3.6M | −$12.6M |
| Net margin | -6.5% | -26.0% |
| Operating cash flow | $5.9M | −$3.3M |
Questions
Which is bigger, Si-Bone or Treace Medical Concepts?
Si-Bone is the larger company: $55.7M of revenue in its latest quarter (Q3 2026) against $48.3M for Treace Medical Concepts (Q3 2026).
Is Si-Bone or Treace Medical Concepts growing faster?
Si-Bone is growing faster (+14% against -4% a year earlier).
Which is more profitable, Si-Bone or Treace Medical Concepts?
Si-Bone is more profitable, with an operating margin of -7.8% against -23.9%.
More: Si-Bone earnings · how Si-Bone makes money · Treace Medical Concepts earnings · how Treace Medical Concepts makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.